Table 1.
Overview of included studies.
| Study ID | Country | Study Duration | Study design | Patients N (intervention/control) | Bridging Intravenous thrombolysis, N (%) | ASPECTS, Median (Range) | Main inclusion criteria |
|---|---|---|---|---|---|---|---|
| Wu et al., 2018 | China | 2015–2017 | Single-center Prospective Study | 45/68 | 50 (44.2) | Intervention 8 (7–10) Control: 9 (8–10) |
1) LVO within 6 h from onset 2) NIHSS ≥6 3) Occlusion in M1 |
| Wan et al., 2023 | China | 2019–2022 | Single-center Randomized Trial | 71/71 | 0 (0) | NR | 1) LVO within 24 h from onset 2) NIHSS ≥6 3) Occlusion in M1, M2, ICA |
| Chen et al., 2016 | China | 2013–2014 | Single-center Retrospective Study | 26/- | NR | Intervention: 6 (6–9) | 1) LVO within 8 h from onset 2) NIHSS ≥8 3) Occlusion in M1, M2, ICA, BA, VA |
| Li et al., 2023 | China | 2020–2022 | Single-center Single-arm Prospective Study | 20/20 | NR | Intervention 8.4 (1.05) * Control: 8.4 (0.83) * |
1) LVO achieving TICI 2b |
| Tian et al., 2023 | China | 2018–2022 | Single-center Prospective Study | 62/80 | 29 (20.4) | NR | 1) Within 24 h from onset 2) NIHSS ≥6 3) Occlusion in M1 |
NR indicates Not reported; ASPECTS, Alberta stroke program early computerized tomography score; LVO, Large vessel occlusion; NIHSS, National institutes of health stroke scale; M1, First segment of the middle cererbral artery; M2, Second segment of the middle cererbral artery; ICA, Internal caratoid artery; BA, Basilar artery; VA, Vertebral artery; TICI, Thrombolysis in cerebral infarction.
* Data is described as mean (standard deviation).